An estimated two million older Americans who qualify for Medicare’s Extra Help program never enroll in it, and the savings they leave unclaimed add up to roughly $11.4 billion in prescription-drug costs every year. Extra Help, formally the Part D Low-Income Subsidy, erases the drug-plan deductible, covers or sharply reduces the monthly premium, and caps what a beneficiary pays at the pharmacy counter. The money is already appropriated and waiting to be drawn down. What stops two million eligible people from taking it is rarely a lack of need and almost always a lack of awareness that the subsidy exists, or a mistaken belief that their income is too high to qualify.
What Extra Help erases from a drug bill
The program attacks the three costs that make Part D coverage expensive for a fixed-income household. It zeroes out the annual deductible, which on a standard plan can run several hundred dollars before coverage even begins. It pays all or part of the monthly premium on a benchmark plan, so many enrollees carry no premium at all. And it collapses the per-prescription copay to a token amount, replacing the percentage coinsurance that can turn a single specialty medication into a monthly financial emergency for someone living on Social Security.
For 2026 the subsidy holds the copay to no more than $12.65 for each covered drug, a ceiling the government sets and adjusts every year. Measured against the coinsurance a full-price enrollee pays once annual spending climbs, that cap is the difference between filling every prescription on schedule and rationing pills to stretch a fixed budget to the end of the month. For a retiree managing three or four chronic conditions, the gap between the two prices runs into the thousands over a full year.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Why two million eligible seniors never sign up
The enrollment gap is not evidence that these households do not need the help. It reflects how the benefit is structured and how poorly the eligibility rules are understood. Medicare grants Extra Help automatically to people who already receive Medicaid, Supplemental Security Income, or a Medicare Savings Program, but everyone else has to apply. Many who would qualify assume the automatic path covers them too, or never learn that the drug subsidy is a separate benefit from the drug plan they already carry.
Advocacy groups that track benefits going unused estimate the total left on the table runs to tens of billions a year, with the Part D subsidy among the single largest pieces. The thresholds are more generous than most applicants expect. The full subsidy reaches households with income up to 150 percent of the federal poverty level, and the 2026 resource limits are $16,590 for a single person and $33,100 for a married couple, with higher allowances when money is earmarked for burial expenses. A worker who once earned too much can cross into eligibility the year the paycheck stops, and nothing in the system prompts a fresh look.
How the subsidy gets claimed
The application runs through the Social Security Administration rather than a private insurer, and filing it costs nothing. There is no annual enrollment season for Extra Help itself, so a person can apply at any point in the year, and approval reaches back to the month eligibility began in many cases. The form asks about income and resources rather than medical history, and a decision generally arrives within a few weeks of a complete submission.
Filing the Extra Help application also does more than cut drug costs. Social Security forwards qualifying applications to the state Medicaid agency to screen for a Medicare Savings Program, which can pay the Part B premium otherwise deducted from a monthly Social Security check. That premium runs more than $185 a month in 2026, often larger than the drug savings itself, so a single application can restore hundreds of dollars a year that a beneficiary never realized they were entitled to reclaim.
The persistence of the gap is what makes it striking. Mailings, outreach campaigns, and automatic screening have run for years, yet roughly the same two million eligible people stay unenrolled cycle after cycle and the unclaimed total barely moves. Part of the explanation is churn: households age into eligibility, lose it when income shifts, and age back in again, so the pool refills faster than any outreach effort can drain it.
For the individual household, the arithmetic is simpler than the national figure suggests. A person who qualifies but never applies pays full freight on every prescription while an identical neighbor pays $12.65, and the difference compounds across a year of refills for the same conditions. The $11.4 billion is not an abstraction hovering over the program; it is the sum of thousands of individual pharmacy receipts that could have read far less, one uncashed subsidy at a time.
This article was produced with AI assistance and reviewed against primary sources by The Money Overview editorial team.
More Financial Reading
